A prospective study of the incidence of childhood celiac disease.

OBJECTIVES To estimate the frequency of celiac disease (CD) in children in the general population of Denver, Colorado. STUDY DESIGN From 22,346 newborns characterized as expressing 0, 1, or 2 HLA-DR3(DQB1*0201) alleles, 987 were selected for a prospective stratified cohort study. Participants were followed for as long as 7 years with serial testing for serum IgA anti-transglutaminase antibodies and for evidence of CD (intestinal mucosal changes or persistent seropositivity). RESULTS Of 40 children with at least one positive serologic test, 19 had evidence of CD (10 by biopsy, 9 by persistent seropositivity). Those expressing 0, 1, or 2 HLA-DR3 alleles had, respectively, 0.3% (95% CI, 0.0-2.7), 3.4% (3.0-11.7), and 3.2% (1.0-11.0) risk for evidence of CD by age 5 years. The adjusted risk estimate for evidence of CD by age 5 years for the Denver general population was 0.9% (0.4-2.0), or 1 in 104 (1:49-221). After adjusting for number of HLA-DR3 alleles expressed, risk was higher in females: RR=3.34 (1.00-10.9, P=.048). Evidence of CD was not observed before age 2.6 years. CONCLUSIONS Celiac disease may affect 0.9% of Denver children by 5 years of age. Children positive for the HLA-DR3 allele and females appear to be at increased risk.

[1]  Jorma Ilonen,et al.  Prevalence of Celiac disease among children in Finland. , 2003, The New England journal of medicine.

[2]  J. Murray,et al.  Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. , 2003, Archives of internal medicine.

[3]  M. Martinetti,et al.  Celiac disease in children with autoimmune thyroid disease. , 2001, The Journal of pediatrics.

[4]  K. Boberg,et al.  The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. , 2001, Scandinavian journal of gastroenterology.

[5]  A. Fasano,et al.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. , 2001, Gastroenterology.

[6]  F. Pérez-Bravo,et al.  Celiac Disease in a Chilean Population Carrying Amerindian Traits , 2000, Journal of pediatric gastroenterology and nutrition.

[7]  M. Rewers,et al.  Transglutaminase antibodies in children with a genetic risk for celiac disease. , 2000, The Journal of pediatrics.

[8]  L. Greco,et al.  The controversial epidemiology of coeliac disease , 2000, Acta paediatrica.

[9]  L. Nyström,et al.  Epidemic of coeliac disease in Swedish children , 2000, Acta paediatrica.

[10]  M. Rewers,et al.  One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. , 1999, Journal of autoimmunity.

[11]  L. Greco,et al.  Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. , 1999, Gastroenterology.

[12]  J. Murray,et al.  The widening spectrum of celiac disease. , 1999, The American journal of clinical nutrition.

[13]  V. Kosma,et al.  Osteoporosis in adult patients with celiac disease. , 1999, Bone.

[14]  M. T. Pellecchia,et al.  False negative polymerase chain reaction on cerebrospinal fluid samples in tuberculous meningitis , 1999, Journal of neurology, neurosurgery, and psychiatry.

[15]  M. Manns,et al.  6 Autoimmune polyglandular syndromes , 1998 .

[16]  G. Coppa,et al.  Celiac disease in the general population: should we treat asymptomatic cases? , 1997, Journal of pediatric gastroenterology and nutrition.

[17]  S. Mcmillan,et al.  Factors associated with serum antibodies to reticulin, endomysium, and gliadin in an adult population. , 1996, Gut.

[18]  G. Coppa,et al.  The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school‐age subjects , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[19]  E. Grodzinsky.  Screening for coeliac disease in apparently healthy blood donors , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[20]  A. Ferguson,et al.  Coeliac disease and malignancies , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[21]  C. Catassi,et al.  High prevalence of undiagnosed coeliae disease in 5280 Italian students screened by antigliadin antibodies , 1995, Acta paediatrica.

[22]  C. Geyer,et al.  Maximum likelihood for interval censored data: Consistency and computation , 1994 .

[23]  E. Thorsby,et al.  HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. , 1992, Human immunology.

[24]  D. Finkelstein,et al.  A proportional hazards model for interval-censored failure time data. , 1986, Biometrics.

[25]  N. Maclaren,et al.  Autoimmune polyglandular syndromes. , 1980, Pediatric annals.

[26]  B. Turnbull.  The Empirical Distribution Function with Arbitrarily Grouped, Censored, and Truncated Data , 1976 .

[27]  J. Murray,et al.  Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States , 2003 .

[28]  C. Wijmenga,et al.  When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. , 2001, European journal of gastroenterology & hepatology.

[29]  A. Bredberg,et al.  Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. , 2001, Pediatrics.

[30]  G. Niro,et al.  Combination therapy (Tx) of interferon (IFN)+ lamivudine (LAM) in HBV related chronic hepatitis (CH) , 2000 .

[31]  W. Pan.  A comparison of some two-sample tests with interval censored data , 1999 .

[32]  J. Partanen,et al.  Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. , 1998, Scandinavian journal of gastroenterology.

[33]  J. Drijfhout,et al.  Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule , 1997, Immunogenetics.

[34]  M. Newton.  Approximate Bayesian-inference With the Weighted Likelihood Bootstrap , 1994 .

[35]  M N Marsh,et al.  Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). , 1992, Gastroenterology.

[36]  S. Guandalini,et al.  Revised criteria for diagnosis of coeliac disease , 1990 .